The results bring Eli Lilly’s pill orforglipron one step closer to becoming a new, needle-free alternative in the booming weight loss and diabetes market.
Related Posts
Trump to address CEOs at Business Roundtable as market sell-off continues
The remarks are scheduled amid an ongoing market sell-off that experts say is fueled in large part by Trump’s tariffs and resulting economic uncertainty.
ASML just gave us a first glimpse into how U.S. chip export curbs will dent its China sales
ASML on Tuesday offered the first glimpse into how U.S. restrictions on exports of its advanced chip manufacturing tools to China will impact its sales […]
Traders betting Fed will cut rates at least 4 times this year to bail out economy
Data from the CME Group on Friday showed raised odds the federal funds rate will fall to 3.00% to 3.25%, down from 4.25% to 4.50% […]